Skip to main content
Premium Trial:

Request an Annual Quote

Beckman to Acquire Specialty Endocrine Testing Firm Diagnostic Systems Laboratories

NEW YORK, Oct. 7 (GenomeWeb News) - Beckman Coulter will acquire specialty immunoassay provider Diagnostic Systems Laboratories of Webster, Texas, the company said today.

 

The price Beckman will pay for DSL was not immediately available. Beckman expects to close the acquisition in mid-October.

 

DSL, which had approximately $34 million in sales last year, markets three reproductive endocrinology tests and holds exclusive rights to a potential biomarker of cardiovascular risk. "Coupling DSL's expertise and proprietary tests with Beckman Coulter's ... immunoassay platforms should be a winning combination," said Michael Whelan, group vice president of Beckman's immunoassay business, in a satatement.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.